Health news
Pfizer and BioNTech announced positive findings from a study evaluating 2 Omicron-adapted COVID-19 vaccine candidates. The phase 2/3 trial assessed the safety, tolerability, and immunogenicity of a booster (fourth) dose of an Omicron-adapted monovalent vaccine…
Additional findings were announced from a phase 2/3 study evaluating the efficacy and safety of Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) in patients with COVID-19 who are at standard risk of progressing to severe…
Good news for people with food allergies — having a food allergy cuts your risk of being infected with COVID-19 by half, according to the results of the Human Epidemiology and Response to SARS-CoV-2 (HEROS)…
Treatment with molnupiravir reduced the risk of an acute care visit in nonhospitalized adults with mild to moderate COVID-19 who were at high risk for progressing to severe disease, according to new data from the…
Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) continues to be recommended for early stage treatment of mild to moderate COVID-19 among individuals at high risk of progression to severe disease, despite reports of COVID-19 rebound,…
The Food and Drug Administration (FDA) has approved the intravenous (IV) formulation of Tpoxx® (tecovirimat) for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients. Previously, Tpoxx was only…
The Food and Drug Administration (FDA) has declined to issue an Emergency Use Authorization (EUA) for fluvoxamine maleate for COVID-19 treatment due to insufficient data supporting its use. The submission for EUA included data from…
The Food and Drug Administration (FDA) has authorized for emergency use the Labcorp Seasonal Respiratory Virus RT-PCR direct-to-consumer (DTC) Test for use without a prescription by individuals 2 years of age and older with symptoms…
Patients with psoriasis have an increased risk for severe and rare infections, according to findings from a study published in the British Journal of Dermatology. The population-based cohort study used data from Danish administrative registries…
Fagron is voluntarily recalling 2 lots of SyrSpend SF Cherry due to a potential contamination with Burkholderia gladioli. The recall is being conducted with the knowledge of the Food and Drug Administration (FDA). SyrSpend SF…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021